General Surgery Unit, ASST Brianza, Vimercate Hospital, Via Santi Cosma e Damiano, 10, 20871, Vimercate, Italy.
Unit of Urological Robotic Surgery and Renal Transplantation, Careggi Hospital, University of Florence, Largo Piero Palagi, 1, 50139, Florence, Italy.
BMC Surg. 2021 May 27;21(1):265. doi: 10.1186/s12893-021-01272-6.
Entero-colovesical fistula is a rare complication of various benign and malignant diseases. The diagnosis is prominently based on clinical symptoms; imaging studies are necessary not only to confirm the presence of the fistula, but more importantly to demonstrate the extent and the nature of the fistula. There is still a lack of consensus regarding the if, when and how to repair the fistula. The aim of the study is to review the different surgical treatment options, focus on surgical indications, and explore cumulative recurrence, morbidity, and mortality rates of entero-vesical and colo-vesical fistula patients.
A systematic review of the literature was conducted according to PRISMA guidelines. Random effects meta-analyses of proportions were developed to assess primary and secondary endpoints. I statistic and Cochran's Q test were computed to assess inter-studies' heterogeneity.
Twenty-two studies were included in the analysis with a total of 861 patients. Meta-analyses of proportions pointed out 5, 22.2, and 4.9% rates for recurrence, complications, and mortality respectively. A single-stage procedure was performed in 75.5% of the cases, whereas a multi-stage operation in 15.5% of patients. Palliative surgery was performed in 6.2% of the cases. In 2.3% of the cases, the surgical procedure was not specified. Simple and advanced repair of the bladder was performed in 84.3% and 15.6% of the cases respectively.
Although burdened by a non-negligible rate of complications, surgical repair of entero-colovesical fistula leads to excellent results in terms of primary healing. Our review offers opportunities for significant further research in this field. Level of Evidence Level III according to ELIS (SR/MA with up to two negative criteria).
肠-膀胱瘘是各种良性和恶性疾病的罕见并发症。诊断主要基于临床症状;影像学研究不仅是必要的,以确认瘘的存在,更重要的是要展示瘘的程度和性质。关于是否、何时以及如何修复瘘管,仍缺乏共识。本研究的目的是回顾不同的手术治疗选择,重点关注手术适应证,并探讨肠-膀胱瘘和结肠-膀胱瘘患者的累积复发率、发病率和死亡率。
根据 PRISMA 指南进行系统文献回顾。采用随机效应荟萃分析评估主要和次要终点。计算 I 统计量和 Cochran's Q 检验来评估研究间的异质性。
共纳入 22 项研究,总计 861 例患者。比例荟萃分析指出,复发、并发症和死亡率的比例分别为 5%、22.2%和 4.9%。75.5%的病例采用一期手术,15.5%的病例采用多期手术。6.2%的病例行姑息性手术。6.2%的病例未指定手术方式。84.3%的病例行简单膀胱修复,15.6%的病例行高级膀胱修复。
尽管并发症发生率较高,但肠-结肠瘘的手术修复在初次愈合方面可获得极好的效果。本综述为该领域的进一步研究提供了机会。根据 ELIS(SR/MA 最多有两个负标准),证据水平为 III 级。